Clear the Air With New COPD Guidelines
February 2026
Patients with COPD will start daily inhalers sooner...as part of the updated COPD guidelines to improve symptoms and decrease mortality.
For acute symptom relief in all patients with COPD, continue to recommend a prn short-acting beta agonist (SABA), such as albuterol...or a short-acting muscarinic antagonist (SAMA), such as ipratropium.
A SABA/SAMA combo can improve symptoms over either product alone...and may mitigate side effects from higher doses of single agents.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote